Targeting the MEK1/2 pathway to combat Staphylococcus aureus infection and inflammation in cystic fibrosis
ABSTRACT Staphylococcus aureus infections remain an ongoing challenge for people with cystic fibrosis (PwCF), with the increased global prevalence of multidrug-resistant strains requiring new therapeutic approaches. Our previous studies demonstrated anti-inflammatory effects of several MEK1/2 inhibi...
Saved in:
Main Authors: | Eryn Zuiker, Gregory Serpa, Mithu De, Yiwei Liu, Daniel J. Wozniak, Kymberly M. Gowdy, Jean Charron, Susan E. Birket, Megan R. Kiedrowski, Emily A. Hemann, Matthew E. Long |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Microbiology
2025-07-01
|
Series: | mBio |
Subjects: | |
Online Access: | https://journals.asm.org/doi/10.1128/mbio.00775-25 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of MEK1/2 blocker U0126 on the medial preoptic synapse and behavioral selection of male mice
by: Yumi Hamasaki, et al.
Published: (2025-09-01) -
Characterization of Batumin Resistant Variants of Staphylococcus aureus Clinical Isolates
by: L. N. Churkina, et al.
Published: (2020-05-01) -
Salidroside represses proliferation, migration and invasion of human lung cancer cells through AKT and MEK/ERK signal pathway
by: Mei Ren, et al.
Published: (2019-12-01) -
Use of cefoxitin as indicator for detection of Methicillin Resistant Staphylococcus aureus
by: Baghdad Science Journal
Published: (2011-12-01) -
Identification and antagonistic mechanism of strains against Staphylococcus aureus
by: ZHANG Shuaiwen, XIONG Dawei, GU Bintao, ZHANG Cheng, LI Peng, HUANG Guochang
Published: (2025-05-01)